×
About 145 results

ALLMedicine™ Adrenal Cancer Center

Research & Reviews  45 results

Cancer risk in adrenalectomy: are adrenal lesions equal or more than 4 cm a contraindic...
https://doi.org/10.1007/s00464-021-08380-7 10.1016/S0039-6109(05)70459-X 10.1007/s00268-020-05759-w 10.1007/s13304-019-00675-8 10.1007/s00464-018-6601-6 10.1007/s00464-013-3169-z 10.1001/archsurg.2009.191 10.1016/S2213-8587(16)00086-3 10.1016/j.eururo.2013.09.021 10.1007/s00464-014-3528-4 10.1007/s00464-018-6309-7 10.1097/00000658-199705000-00006 10.1016/S0022-5347(01)67471-8 10.1016/j.ijsu.2012.12.007 10.1016/j.ijsu.2009.04.011 10.1007/BF02557272 10.1016/j.urology.2007.12.019 10.1002/bjs.4964 10.1016/j.surg.2012.02.003 10.1016/S1470-2045(04)01647-X 10.1002/jso.20180 10.1016/j.mayocpiqo.2017.11.002 10.4158/EP-2018-0616 10.3390/ijerph16101872 10.1097/SLA.0000000000004048 10.1007/s00268-019-05287-2 10.1097/SLA.0b013e3181b13ca2 10.1245/s10434-012-2760-1 10.1530/EJE-09-1096 10.1016/j.surg.2005.09.012 10.1007/s00464-013-3034-0 10.1089/end.2000.14.149 10.1007/s00464-015-4643-6 10.5489/cuaj.11135 10.4158/EP.15.5.450 10.1016/j.surg.2014.06.042 10.1002/cncr.23886 10.1210/jc.2006-0706 10.1001/jamasurg.2018.2648 10.1245/s10434-020-08454-1 10.21037/gs.2019.10.15 10.4103/0972-9941.103110 10.1159/000444146 10.1111/iju.13524 10.21037/tau.2016.08.10 10.1007/s00268-017-4290-2 10.1002/bjs.8921 10.1007/s00464-016-4830-0
Surgical Endoscopy; Balla A, Corallino D et. al.

Mar 3rd, 2021 - Some authors consider adrenal lesions size of less than 4 cm as a positive cut-off limit to set the indications for minimally invasive surgery due to a lower risk of malignancy. Aim of this study is to report the risk of cancer for adrenal lesions...

Robotic and Laparoscopic Approaches for Adrenal Surgery in Obese Patients.
https://doi.org/10.1177/0003134820951498
The American Surgeon; Shalaby H, Abdelgawad M et. al.

Nov 3rd, 2020 - Minimally invasive adrenalectomy is a challenging procedure in obese patients. Few recent studies have advocated against robot-assisted adrenalectomy, particularly in obese patients. This study aims to compare operative outcomes between the roboti...

Uncommon tumors in multiple endocrine neoplasia (MEN) type 1: Do they have a relationsh...
https://doi.org/10.1007/s40618-020-01414-2 10.1007/s00268-009-0290-1 10.1007/s002689900438 10.1210/jc.2012-1230 10.1530/EJE-11-0679 10.1016/j.medcli.2017.04.034 10.1007/s00268-009-9980-y 10.1111/cen.13480 10.1210/jc.2016-3690
Journal of Endocrinological Investigation; Febrero B, Segura P et. al.

Sep 11th, 2020 - The prognosis of MEN 1 patients is not only determined by pancreatic disease; it is also related to other uncommon tumors. The objective of this study is to analyze the tumors associated with MEN 1 outside the classic triad and to investigate thei...

Delaying Cancer Cases in Urology during COVID-19: Review of the Literature.
https://doi.org/10.1097/JU.0000000000001288
The Journal of Urology; Tachibana I, Ferguson EL et. al.

Jul 22nd, 2020 - Coronavirus disease 2019 (COVID-19) is a global pandemic affecting hospital systems and the availability of resources for surgical procedures. Our aim is to provide guidance for urologists to help prioritize urological cancer surgeries. We reviewe...

see more →

Guidelines  1 results

Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
https://doi.org/10.1093/annonc/mds231
Annals of Oncology : Official Journal of the European Soc... Berruti A, Baudin E et. al.

Nov 20th, 2012 - Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.|2012|Berruti A,Baudin E,Gelderblom H,Haak HR,Porpiglia F,|diagnosis,pathology,therapy,diagnosis,secondary,therapy,therapeutic use,therapeutic use,therapeutic...

see more →

Clinicaltrials.gov  3 results

Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)
https://clinicaltrials.gov/ct2/show/NCT00094497

Sep 21st, 2016 - The Firm-ACT trial is the first ever conducted randomized controlled phase III trial in adrenocortical carcinoma (ACC), a rare malignancy with poor prognosis. It will provide results leading to the establishment of an urgently needed gold standard...

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
https://clinicaltrials.gov/ct2/show/NCT00002608

Jul 10th, 2013 - OBJECTIVES: Determine the feasibility and efficacy of cisplatin, doxorubicin, and tamoxifen (CAT) in patients with soft tissue sarcoma, glioma, mesothelioma, hepatoma, thyroid cancer, or adrenal cancer. Determine the toxicity of this regimen in th...

Towards an Easy-to-use Adrenal Cancer/Tumor Identity Card
https://clinicaltrials.gov/ct2/show/NCT02672020

Malignant pheochromocytoma/paraganglioma (MPP) and adrenocortical carcinoma (ACC) are two rare cancer entities with a very unfavorable prognosis. The knowledge on these rare cancers improved thanks to the French COMETE ('COrtex, MEdulla Tumors End...

see more →

News  4 results

Urine Screen as Part of Triple Test Improves ID of Adrenal Cancer
https://www.medscape.com/viewarticle/934790

Jul 29th, 2020 - A strategy that includes a urine steroid test along with imaging characteristics and tumor size criteria can significantly improve the challenging diagnosis of adrenocortical cancer, helping to avoid unnecessary, and often unsuccessful, further im...

Post-Stenting DAPT; Incidentalomas: It's PodMed Double T!
https://www.medpagetoday.com/cardiology/myocardialinfarction/80770

Jun 29th, 2019 - PodMed Double T is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center in El Paso, look at the top me...

Endocrine Society to the White House: Immigration ban undermines science
https://www.mdedge.com/endocrinology/article/130649/practice-management/endocrine-society-white-house-immigration-ban
Sally Koch Kubetin

Feb 2nd, 2017 - The immigration ban from seven Muslim-majority countries issued recently by the Trump administration is having the unintended effect of disrupting scientific collaboration, according to a statement issued by the Endocrine Society. “President Donal.

Interventional Cardiologist Donald Baim Dies
https://www.medscape.com/viewarticle/712050

Nov 9th, 2009 - November 9, 2009 (Boston, Massachusetts) — Interventional cardiologist Dr Donald Baim, chief medical and scientific officer at Boston Scientific, has died due to complications of surgery for treating recently diagnosed adrenal cancer. A message se...

see more →

Patient Education  5 results see all →